Resistoflavine, cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN1/7

School of Pharmacy, International Medical University, Sesama Center, Plaza, Komanwel, Bukit jalil, 57000 Kuala Lumpur, Malaysia.
Microbiological Research (Impact Factor: 2.56). 02/2007; 162(4):322-7. DOI: 10.1016/j.micres.2006.01.012
Source: PubMed


In our systematic screening programme for marine actinomycetes, a bioactive Streptomycete was isolated from marine sediment samples of Bay of Bengal, India. The taxonomic studies indicated that the isolate belongs to Streptomyces chibaensis and it was designated as S. chibaensis AUBN1/7. The isolate yielded a cytotoxic compound. It was obtained by solvent extraction followed by the chromatographic purification. Based on the spectral data of the pure compound, it was identified as quinone-related antibiotic, resistoflavine (1). It showed a potent cytotoxic activity against cell lines viz. HMO2 (Gastric adenocarcinoma) and HePG2 (Hepatic carcinoma) in vitro and also exhibited weak antibacterial activities against Gram-positive and Gram-negative bacteria.

Download full-text


Available from: Saisha Vinjamuri, Mar 06, 2014
  • Source
    • "present in an additional two extracts (1477E and 1494E), which are also present in Cluster A. The identity of each compound was verified by (À)-FTICR MS and analysis of NMR spectra (Figure S1). All three of these compounds have reported cytotoxicity against mammalian cells (Martin et al., 2002; Gorajana et al., 2007; Vijayabharathi et al., 2011). Furthermore, resistomycin has recently been shown to bind DNA by fluorescence competition experiments and circular dichroism studies (Vijayabharathi et al., 2012), and to prevent transcription by inhibition of RNA polymerase (Arora, 1985). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cytological profiling is a high-content image-based screening technology that provides insight into the mode of action (MOA) for test compounds by directly measuring hundreds of phenotypic cellular features. We have extended this recently reported technology to the mechanistic characterization of unknown natural products libraries for the direct prediction of compound MOAs at the primary screening stage. By analyzing a training set of commercial compounds of known mechanism and comparing these profiles to those obtained from natural product library members, we have successfully annotated extracts based on MOA, dereplicated known compounds based on biological similarity to the training set, and identified and predicted the MOA of a unique family of iron siderophores. Coupled with traditional analytical techniques, cytological profiling provides an avenue for the creation of "function-first" approaches to natural products discovery.
    Chemistry & biology 02/2013; 20(2):285-95. DOI:10.1016/j.chembiol.2012.12.007 · 6.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Secondary metabolites obtained from Actinomycetales provide a potential source of many novel compounds with antibacterial, antitumour, antifungal, antiviral, antiparasitic and other properties. The majority of these compounds are widely used as medicines for combating multidrug-resistant Gram-positive and Gram-negative bacterial strains. Members of the genus Streptomyces are profile producers of previously-known secondary metabolites. Actinomycetes have been isolated from terrestrial soils, from the rhizospheres of plant roots, and recently from marine sediments. This review demonstrates the diversity of secondary metabolites produced by actinomycete strains with respect to their chemical structure, biological activity and origin. On the basis of this diversity, this review concludes that the discovery of new bioactive compounds will continue to pose a great challenge for scientists.
    Central European Journal of Biology 06/2012; 7(3). DOI:10.2478/s11535-012-0036-1 · 0.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Studies of the origin of bioactive metabolites of marine actinomycetes are reviewed. Structures and properties of new metabolites from indigenous marine bacteria from Actinomycetales order, such as a benzanthraquinone antibiotic from a strain of the Chainia purpurogena, istamycins, aplasmomycins, altemicidin, new phenazine esters. C13-butanolide, marinone and debromomarinone, palmyromycin, urauchimicins and some others compounds are presented. Prospects of marine biotechnology and microbiology (with considerable emphasis on the development of the basis biology of marine microorganisms in cultures collection) are discussed.
    Bioorganicheskaia khimiia 02/1995; 21(1):3-8.
Show more